- Filed
- May 21, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 8, 2026 | 46.71M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 946K sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 946K sh |
| Capex | Q1 2026 · Mar 31, 2026 | $112K |
| Capex | Q1 2026 · Mar 31, 2025 | $16K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$21.58M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$13.03M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $49.86M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $87.97M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$198.62M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$176.64M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $13.19M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $10.68M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $13.71M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $11.25M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $169.43M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $192.55M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $175.26M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $194.78M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$23.98 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$16.18 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$23.98 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$16.18 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $4.15M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $2.46M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $19.46M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $14.1M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$22.69M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$15.31M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$23.61M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$16.56M |